Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,505.00    -46.00 (-1.80%)
Bid:
2,516.00
Ask:
2,518.00
Spread: 2.00 (0.079%)
Market Cap: £22.28b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Director/PDMR Shareholding

17 Jun 2025 14:00

RNS Number : 2159N
Experian plc
17 June 2025
 

Experian plc

 

 

Director/PDMR Shareholding

 

 

17 June 2025 - Experian plc, the global data and technology company, hereby notifies the market that it has received notification (made under article 19.1 of the UK Market Abuse Regulation ("MAR")) of the following transactions in its ordinary shares of 10 US cents each ("ordinary shares") by directors of the Company.

 

Co-Investment Plan

 

In accordance with the terms of the Experian Co-Investment Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,746.27 pence per share. The awards of deferred matching ordinary shares are subject to performance conditions and the maximum numbers of shares that could vest in the case of each director are set out below.

Name of director/PDMR

Number of deferred

ordinary shares

Maximum number of deferred matching ordinary shares

Brian Cassin

30,157

113,802

Lloyd Pitchford

21,221

80,079

 

Note: The deferred ordinary share awards for Brian Cassin and Lloyd Pitchford were calculated with reference to their bonuses net of tax. All deferred matching ordinary share awards were calculated on a gross basis and will be taxed at the point of vesting.

 

Performance Share Plan

 

In accordance with the terms of the Experian Performance Share Plan, the Company made awards over its ordinary shares on 13 June 2025 to certain directors by reference to a price of 3,775.30 pence per share. The awards are subject to performance conditions and the maximum number of shares that could vest in the case of each director is set out below.

 

Name of director/PDMR

Maximum number

of ordinary shares

Brian Cassin

71,516

Lloyd Pitchford

40,791

 

The following individual notifications are made in accordance with Article 19.3 of MAR.

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Natural Person

Brian Cassin

 

 

2 - Reason for the notification

 

 

 

Position/status

Director and Chief Executive Officer

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

 

Full name of the entity

Experian plc

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

 

 

4 - Details of the transaction(s)

 

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

Identification Code

GB00B19NLV48

 

 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

 

 

Currency

GBP

 

 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2)

Nil

113,802

No (3)

Nil

71,516

 

 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

30,157

No (2) and (3)

Nil

185,318

 

 

Date of Transaction

 

2025-06-13

 

 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

 

 

 

 

 

 

1 - Details of the person discharging managerial responsibilities / person closely associated

 

 

 

Natural Person

Lloyd Pitchford

 

 

2 - Reason for the notification

 

 

 

Position/status

Director and Chief Financial Officer

 

 

Initial notification / Amendment

Initial Notification

 

 

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

 

Full name of the entity

Experian plc

 

 

Legal Entity Identifier code

635400RXXHHYT1JTSZ26

 

 

 

 

4 - Details of the transaction(s)

 

 

 

 

Description of the financial instrument, type of instrument

 

Ordinary shares of US 10 cents each in Experian plc

 

Identification Code

GB00B19NLV48

 

 

Nature of transaction

(1) Acquisition of shares, being the award of Invested Shares ("deferred ordinary shares") for market value under the Experian Co-Investment Plan.

 

(2) Grant of a conditional right to receive shares for nil consideration, being the grant of a Matching Award ("deferred matching ordinary shares") under the Experian Co-Investment Plan.

 

(3) Grant of a conditional right to receive shares for nil consideration, being the grant of an award under the Experian Performance Share Plan.

 

 

Currency

GBP

 

 

Prices(s) and volumes(s)

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2)

Nil

80,079

No (3)

Nil

40,791

 

 

Aggregated Information

Transaction

Price

Volume

No (1)

3,746.27 pence

21,221

No (2) and (3)

Nil

120,870

 

 

Date of Transaction

 

2025-06-13

 

 

Place of transaction

Acquisition: XLON

Grant of conditional rights: Outside a trading venue

 

 

 

 

Experian

Claire Murphy Deputy Company Secretary +353 (0) 87 421 3311

 

 

About Experian

 

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

 

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGPUBGQUPAGGM
Date   Source Headline
5th Apr 20175:19 pmRNSTransaction in Own Shares
3rd Apr 20179:00 amRNSExperian agrees to sell Email/CCM business
31st Mar 201710:33 amRNSTotal Voting Rights
16th Mar 20179:10 amRNSBlock listing Interim Review
10th Mar 20173:15 pmRNSDirector/PDMR Shareholding
28th Feb 20175:33 pmRNSTransaction in Own Shares
28th Feb 201712:59 pmRNSIrrevocable and non-discretionary arrangement
28th Feb 201710:18 amRNSTotal Voting Rights
27th Feb 20178:30 amRNSDirector Declaration
3rd Feb 20175:04 pmRNSTransaction in Own Shares
2nd Feb 20175:28 pmRNSTransaction in Own Shares
1st Feb 20175:37 pmRNSTransaction in Own Shares
1st Feb 20179:44 amRNSAdditional Listing
31st Jan 20175:04 pmRNSTransaction in Own Shares
31st Jan 20179:30 amRNSTotal Voting Rights
30th Jan 20175:17 pmRNSTransaction in Own Shares
27th Jan 20175:00 pmRNSTransaction in Own Shares
26th Jan 20175:12 pmRNSTransaction in Own Shares
25th Jan 20175:15 pmRNSTransaction in Own Shares
25th Jan 20172:45 pmRNSDirector/PDMR Shareholding
24th Jan 20175:28 pmRNSTransaction in Own Shares
23rd Jan 20175:57 pmRNSTransaction in Own Shares - Replacement
23rd Jan 20174:54 pmRNSTransaction in Own Shares
20th Jan 20174:50 pmRNSTransaction in Own Shares
19th Jan 20172:44 pmRNSTransaction in Own Shares
18th Jan 20173:05 pmRNSTransaction in Own Shares
18th Jan 20177:00 amRNSTrading update, third quarter
6th Jan 20175:30 pmRNSFirst interim dividend
30th Dec 20161:25 pmRNSTotal Voting Rights
30th Dec 201610:00 amRNSShare buy-back programme
14th Dec 20165:48 pmRNSTransaction in Own Shares
14th Dec 201611:10 amRNSAdditional Listing
13th Dec 20165:30 pmRNSTransaction in Own Shares
12th Dec 20165:29 pmRNSTransaction in Own Shares
9th Dec 20165:53 pmRNSTransaction in Own Shares
9th Dec 201612:30 pmRNSElections for first interim dividend
8th Dec 20165:29 pmRNSTransaction in Own Shares
7th Dec 20165:26 pmRNSTransaction in Own Shares
6th Dec 20166:06 pmRNSTransaction in Own Shares
5th Dec 20166:03 pmRNSTransaction in Own Shares
2nd Dec 20165:37 pmRNSTransaction in Own Shares
1st Dec 20165:45 pmRNSTransaction in Own Shares
30th Nov 20165:55 pmRNSTransaction in Own Shares
30th Nov 201612:20 pmRNSTotal Voting Rights
29th Nov 20165:29 pmRNSTransaction in Own Shares
28th Nov 20165:20 pmRNSTransaction in Own Shares
25th Nov 20165:57 pmRNSTransaction in Own Shares
24th Nov 20165:51 pmRNSTransaction in Own Shares
23rd Nov 20165:31 pmRNSTransaction in Own Shares
22nd Nov 20165:32 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.